Tissue therapies posts small loss
By Renate Krelle
Thursday, 10 February, 2005
Thursday, 10 February, 2005
Tissue Therapies Limited (ASX:TIS) has released its half-year results, recording a net loss of $445,400, in line with budget expectations.
At December 31, the company had cash reserves of almost $4 million, bolstered by a $1.5 million capital raising in October last year.
It spent $524,000 on research and development, and banked revenue of $152,5000 from research grants and interest.
Related News
MV Hondius passengers return to Australia under strict infection control measures
The Australian CDC has provided an update on hantavirus risk to Australians and infection...
$96m RNA Research and Manufacturing Facility opens in NSW
The new 4500 sqm RNA Research and Manufacturing Facility within the Macquarie University...
Cartherics and Catalent announce enhanced partnership
To support immune cell therapy products for the treatment of cancer and endometriosis, Australian...
